Trade MCRB anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Seres Therapeutics, Inc. (MCRB) is trading at US$5.03, up 1.70% today as of Aug 28, 13:01 EDT. The company has a market capitalisation of US$45.8M. Over the past 52 weeks, MCRB has traded between US$4.32 and US$29.98. On Syfe you can trade MCRB with $0 commission and add it to your watchlist.
| Previous close | US$4.95 |
|---|---|
| Market cap | US$45.8M |
| 52-week range | US$4.32 – US$29.98 |
| Volume | 22.83K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Year: 2015
Sector Update: Healthcare Stocks Lean Lower Pre-Bell Wednesday
Jul 8, 1:13 PM · MT Newswires
Seres Therapeutics' Phase 1 Trial of SER-155 Meets Primary Endpoint; Shares Rise Pre-Bell
Jul 8, 11:55 AM · MT Newswires
--HC Wainwright Initiates Seres Therapeutics at Buy With $12 Price Target
Jun 23, 10:13 AM · MT Newswires
Seres Therapeutics, Inc. (MCRB) stock is trading at US$5.03, +1.70% from the previous close of US$4.95.
The market cap for Seres Therapeutics, Inc. (MCRB) stock is approximately US$45.8M.
The 52-week high for Seres Therapeutics, Inc. (MCRB) stock is US$29.98.
The 52-week low for Seres Therapeutics, Inc. (MCRB) stock is US$4.32.
Seres Therapeutics, Inc. (MCRB) does not currently pay a dividend.
Stay on top of MCRB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
